Moderna, the Vaccine, and the Business Gamble That Changed the World
Presented on: Wednesday, February 15th at 11:00 AM CST
Resources
-
Book
The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World
View Upcoming Events View Past Event Recordings
Peter Loftus, a reporter for The Wall Street Journal covering the pharmaceutical industry, tells the story of Moderna, the biotechnology startup with big ambitions to pioneer a brand new way of making medicines. The small company's scientists and leaders mainly labored in obscurity for ten years before the Covid-19 pandemic and were met with skepticism that they could successfully turn gene-based "messenger RNA" technology into new drugs and vaccines. When the pandemic hit, Moderna seized the moment to embark on one of the most consequential quests in medical history, delivering an effective Covid-19 vaccine within the year--and transforming the company into a household name and industry leader.
In this compelling webinar, Peter Loftus, author of The Messenger: Moderna, the Vaccine and the Business Gamble that Changed the World, will discuss the people behind messenger RNA scientific research and Moderna's inception, the company's growth and setbacks over a decade, its high-stakes response to the pandemic in 2020, and what lies ahead for the company and mRNA technology.
About the author: Peter Loftus has been a journalist for 30 years and is currently a reporter for The Wall Street Journal, covering the drug and medical-device industries and other healthcare topics. He was part of a Journal team that won second place in the business category of the 2020 Association of Health Care Journalists' awards for coverage of the race for a Covid-19 vaccine. In 2016 he was part of a Journal team that was a finalist for the Pulitzer Prize in explanatory reporting for a series of articles about rising prescription drug prices. He has also written about advances in cancer research, drug shortages, and the growing use of mobile devices in healthcare. Before joining the Journal in 2013, he was a Dow Jones Newswires reporter covering the pharmaceutical and technology industries. Before that, he worked for community newspapers in suburban Philadelphia. He lives outside Philadelphia with his wife and three children.
The SIUE Alumni Association is in partnership with the Alumni Learning Consortium (ALC) to provide monthly webinar content. The views and opinions expressed are those of the authors and do not necessarily reflect the official policy or position of SIUE, the SIUE Alumni Association, or their members. Any content provided by the ALC are of their opinion and are not intended to malign any religion, ethnic group, club, organization, company, individual, anyone or anything. Although we make strong efforts to make sure our information is accurate, SIUE Alumni Association cannot guarantee that all the information provided is always correct, complete, or up-to-date.
The SIUE Alumni Association does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned in ALC webinars. Reliance upon the information provided is solely at your own risk. In this regard you agree not to use any information on our website, including but not limited to product descriptions, customer testimonials, etc. for the diagnosis and treatment of any health issue or for the prescription of any medication or treatment.
SIUE Alumni Association makes no representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability or suitability with respect to any content shared in webinars. These webinars are for entertainment purposes only. The SIUE Alumni Association is not responsible for any loss or damage, including without limitation, indirect or consequential loss or damage whatsoever arising from participating in ALC webinars.